Pharmaceutical heavyweight Mylan, the latest poster child for drug-industry greed, finally stuck up for itself Thursday. It argued that “the system,” not avarice, was to blame for the company jacking up the price of EpiPens, a common (and life-saving ...
A key measure of corporate profits rose this spring for a second straight quarter alongside modest growth in the overall economy, though U.S.
Many American farmers pride themselves on being self-reliant. But this year, they're getting more federal money from a Depression-era food purchasing program that's designed to combat a supply glut and low prices.
Dollar General DG has been cutting prices by about 10% on hundreds of staples like milk and eggs as it looks to keep customers who are drifting back to Walmart.
Carl Icahn's exploration of a sale of his Herbalife Ltd. HLF -3.28 % stake to a group of investors including William Ackman is rich with irony, but the nutritional-products company's shareholders aren't amused.